European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Cherry Biotech SAS, Montreuil, France

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Cherry Biotech SAS

Identification

Sirul
Siren 801463902
Siret
Siret 80146390200040
EUID
FR9301.801463902

Address

14 Rue De la Beaune, 93100 Montreuil, France
Rennes, France

Corporate purpose

72.11
Research and experimental development on biotechnology

In France and abroad, research, development, production and marketing of scientific instrumentation for research in biology, biochemistry, chemistry and biotechnology, therapeutic diagnostics and biomedical research.

Financials

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Marketing & Tech

Network

Loading network

Publications

12 Feb 2025
Capital: €20,100 · In France and abroad, research, development, production and marketing of scientific instrumentation for research in biology, biochemistry, chemistry and biotechnology, therapeutic …
2 Sept 2024 in Hor
EU funding (€2,499,831): Multi-organ toxicity and efficacy test platform for Personalized medicine & Drug development
1 May 2024
Patent: Method for GAS Enrichment and Simultaneous Movement of a Fluid and System for Controlling the Cellular Environment on a Corresponding Multiwell Cell Culture Plate
22 Jun 2023
Patent: Method for Controlling Fluid Displacement and GAS(ES) Composition and/or PH in a Cell Culture Device and Corresponding Cell Culture System
1 Nov 2022 in Hor
EU funding (€2,496,073): IDEFIX Multiorgan toxicity and efficacy test platform
20 Sept 2022
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020
20 Sept 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021
1 May 2022 in Hor
EU funding (€472,438): A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy
1 May 2022 in Hor
EU funding (€870,430): Long-term Microphysiological Sample Imaging for Evaluation of Polypharmacy in Liver
6 Oct 2021
President: Jeremy Cramer · Cherry Biotech
4 Oct 2021
President: Jeremy Cramer
2 Aug 2021
Address
30 Nov 2020
Pres.: Jeremy Cramer · In France and abroad, the research, development, production and marketing of scientific instrumentation for research in biology, biochemistry, chemistry and biotechnologies …
27 Nov 2020
President: Jeremy Cramer · No longer Director-General: Thomas Guerinier · No longer President: Thomas Guerinier
29 Oct 2020
Patent: Method and Apparatus for the Electronic Monitoring of Life-Threatening Conditions
Year 2020 in Hor
4 EU fundings (€0.00): Multidisciplinary Training of Young Researchers in Novel Implantable Bio-inspired sensors …
Year 2019 in Hor
6 EU fundings (€274,802): Growth-Special Needs Lump Sum …
6 Mar 2019
Patent: Methods and Apparatus to Provide Environmental Control in Biological Samples Contained in Cell-Culture Dishes
4 Dec 2018
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
4 Dec 2018
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
12 Nov 2018 in Hor
EU funding (€103,051): Research and Training in Early Life Nutrition to Prevent Disease
1 Nov 2018 via Kutxagestion Zerbitzuak SL
EU funding (€42,747): Protometabolic pathways: exploring the chemical roots of systems biology
1 Apr 2018
President: Jeremy S. M. Cramer · Director-General: Thomas Guerinier
21 Feb 2018
Address
28 Dec 2017
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016
Year 2017 in Hor
5 EU fundings (€262,876): Smart thermal management of high-power microprocessors using phase-change …
4 Dec 2016
Chair of the Supervisory Board: Thomas Guerinier · Member of the Supervisory Board: Jeremy Cramer · Vice president (1)
30 Nov 2016
President: Thomas Guerinier · Member of the Supervisory Board: Jeremy S. M. Cramer · Vice president (1)
26 Aug 2016
Modification of the address of the head office..
1 Jul 2016
Address
20 Jul 2015 via Elvesys SAS
EU funding (€262,876): A multidisciplinary approach to cell division: From human oocyte to synthetic biology
11 Dec 2014
President: Jeremy Cramer
17 Jun 2014
President (1)
11 Apr 2014
Capital: €20,000 · In France and abroad, research, development, production and commercialization of scientific instrumentation for research in biology, biochemistry, chemistry and biotechnology …
24 Mar 2014
Address · Legal form · Name: CHERRY BIOTECH · Segment clas­si­fi­ca­tion
There are no publications matching your search.

Mentions

10 Feb 2025 in Rne
Reg­is­tra­tion: 01/07/2021 · Pres.: Jeremy Cramer · Capital: €20,100 · Segment clas­si­fi­ca­tion · The purpose of the company in France and abroad is to: - All operations, in particular consulting …
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Cherry Biotech SAS, Montreuil, France" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.